Skip to main content
. 2022 Jan 2;27(2):86–94. doi: 10.1016/j.slasd.2021.12.005

Fig. 6.

Fig. 6

SARS-CoV-2-S variants PP assays. Concentration-response curves of (a) calpeptin, (b) aloxistatin, (c) apilimod, (d) CAA-0225, (e) brigatinib, and (f) VBY-825 in PP entry assays with Wuhan-Hu-1, B.1.1.7, and B.1.351 spike variants. Data was generated from n=3 technical replicates in 384-well format. Error bars depict SD values.